Medications

Orkambi Price, Side effects, Dosage for Cystic Fibrosis Treatment

Orkambi Price, Side effects, Dosage for Cystic Fibrosis Treatment

Orkambi, breakthrough drugs for Cystic Fibrosis treatment was approved by FDA approved in 2015. Orkambi is orally-delivered medicine in the form of fully co-formulated tablets i.e. a combination therapy that contains two drugs lumacaftor and ivacaftor. Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) is a protein that is responsible for regulating ...

Read More »

Tagrisso/osimertinib side effects, cost, dosage for lung cancer

Tagrisso/osimertinib side effects, cost, dosage for lung cancer

Tagrisso/osimertinib side effects, cost, dosage for lung cancer.Tagrisso is marketed by Astra Zeneca Pharmaceuticals based in Wilmington, Delaware. FDA approves new pill Tagrisso/osimertinib to treat certain patients with non-small cell lung cancer on November 13, 2015. FDA has approved Tagrisso (AZD9291) 80mg once-daily tablets for the treatment of patients with metastatic ...

Read More »

Nucala/Mepolizumab Side effects, Cost, Dosage for Asthma

Nucala/Mepolizumab Side effects, Cost, Dosage for Asthma

Nucala/Mepolizumab Side effects, Cost, Dosage for Asthma. Nucala is marketed by GSK. Nucala mepolizumab is approved by FDA on 4th November 2015.Nucala mepolizumab is an interleukin-5 adversary monoclonal antibody (IgG1 kappa) demonstrated for the extra support or add-on treatment of patients with serious eosinophilic asthma. Nucala is a physician recommended ...

Read More »

Yondelis/Trabectedin Side effects, Cost, Dosage for Leiomyosarcoma and Liposarcoma

Yondelis/Trabectedin Side effects, Cost, Dosage for Leiomyosarcoma and Liposarcoma

Yondelis/Trabectedin Side effects, Cost, Dosage for Leiomyosarcoma and Liposarcoma.Yondelis is marketed by Janssen Products of Raritan, New Jersey. yondelis for Leiomyosarcoma and Liposarcoma. Yondelis/trabectedin is first approved by FDA on 23rd October 2015.Yondelis trabectedin is chemotherapy for the treatment of particular type of soft tissue sarcomas (STS) – liposarcoma and leiomyosarcoma – ...

Read More »

Strensiq/Asfotase Alfa Side effects, Cost, Dosage for Hypophosphatasia

Strensiq-Asfotase Alfa Side effects, Cost, Dosage for Hypophosphatasia

Strensiq/Asfotase Alfa Side effects, Cost, Dosage for Hypophosphatasia. Strensiq is marketed by Alexion pharmaceuticals. Strensiq is approved by FDA on 23rd October 2015.Its active ingredient is asfotase alfa.Strensiq asfotase alfa is used as the initially endorsed treatment for perinatal, infantile and juvenile onset hypophosphatasia (HPP). HPP is an uncommon, hereditary, progressive, ...

Read More »

Genvoya side effects, cost, dosage for HIV Treatment

Genvoya side effects, cost, dosage for HIV Treatment

The population of HIV patient has grown; there is an increased risk for development of treatment-related co morbidities, including low bone mineral density and renal mutilation. But now the world have a solution against such a terrible problem termed as HIV in the form of Genvoya, which has developed from ...

Read More »

Imlygic/Talimogene Laherparepvec Side effects, Cost, Dosage for Melanoma

Imlygic/Talimogene Laherparepvec Side effects, Cost, Dosage for Melanoma

Imlygic/Talimogene Laherparepvec Side effects, Cost, Dosage for Melanoma, FDA approval, Mechanism, Clinical trials. Imlygic is marketed by BioVex Inc., a subsidiary of Amgen Inc. The U.S. Food and Drug Administration approved Imlygic (talimogene laherparepvec) on 27th October 2015, the first FDA-approved oncolytic virus therapy, for the treatment of melanoma lesions in the ...

Read More »

Secukinumab (Cosentyx) Cost, Dosing, Side effects for Psoriatic Arthritis

Secukinumab (Cosentyx) Cost, Dosing, Side effects for Psoriatic Arthritis

Secukinumab (Cosentyx) cost, dosing and side effects as new FDA approved medicine for psoriatic arthritis treatment by East Hanover, New Jersey-based Novartis Pharmaceuticals Corporation. Cosentyx also known as secukinumab is a new medicine was approved by US Food and Drug Administration (FDA) and the European Commission in January 2015. Inactive ...

Read More »

Praluent/Alirocumab Side effects, Cost, Dosage to Lower LDL

Praluent-Alirocumab-Side-effects-Dosage-Cost-to-lower-Cholesterol-LDL

Praluent (Alirocumab) Side effects, Cost, Dosage to lower LDL Cholesterol, by Sanofi-Aventis. Praluent generic name is Alirocumab. Inactive ingredients present in this product are histidine, polysorbate 20, sucrose, and water for injection. Praluent is new medicine, a blockbuster cholesterol reducing agent, approved by FDA in July 24, 2015. It is recommended ...

Read More »

Repatha/Evolocumab Side effects, Cost, Dosage to Lower LDL

Repatha/evolocumab side effects, cost, dosage, mechanism to lower LDL

Repatha (Evolocumab) side effects, cost, adult dosage, children dosage, mechanism and full prescribing information. Repatha is the new to reduce bad LDL cholesterol by Amgen Inc. Repatha is used to treat patients who can’t control their cholesterol levels with cholesterol bringing down diet alone. Repatha was first approved by FDA on August ...

Read More »